Hipercalcemia

Sterling, 2011, Advances in the biology of bone metastasis: how the skeleton affects tumor behaviour, Bone., 48, 6, 10.1016/j.bone.2010.07.015 Matsumoto, 2011, TGF-β related mechanisms of bone destruction in multiple myeloma, Bone., 48, 129, 10.1016/j.bone.2010.05.036 Christensen, 2011, Familial hypocalciuric hypercalcemia: a review, Curr Opin Endocrinol Diabetes Obes., 18, 359, 10.1097/MED.0b013e32834c3c7c Nissen, 2007, Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcaemia: phenotypic variation and mutation spectrum in a Danish population, J Clin Endocrinol Metab., 92, 4373, 10.1210/jc.2007-0322 Christensen, 2008, Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods, Clin Endocrinol (Oxf)., 69, 713, 10.1111/j.1365-2265.2008.03259.x Isaksen, 2011, Forearm bone mineral density in familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a comparative study, Calcif Tissue Int., 89, 285, 10.1007/s00223-011-9517-x Major, 2001, Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials, J Clin Oncol., 19, 558, 10.1200/JCO.2001.19.2.558 Peacock, 2009, Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study, J Clin Endocrinol Metab., 94, 4860, 10.1210/jc.2009-1472 Marcocci, 2009, Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism, J Clin Endocrinol Metab., 94, 2766, 10.1210/jc.2008-2640